Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2006 Dec 4;95(11):1537-44.
doi: 10.1038/sj.bjc.6603447. Epub 2006 Nov 21.

Authenticity and drug resistance in a panel of acute lymphoblastic leukaemia cell lines

Affiliations
Comparative Study

Authenticity and drug resistance in a panel of acute lymphoblastic leukaemia cell lines

A H Beesley et al. Br J Cancer. .

Abstract

Cell lines are important models for drug resistance in acute lymphoblastic leukaemia (ALL), but are often criticised as being unrepresentative of primary disease. There are also doubts regarding the authenticity of many lines. We have characterised a panel of ALL cell lines for growth and drug resistance and compared data with that published for primary patient specimens. In contrast to the convention that cell lines are highly proliferative, those established in our laboratory grow at rates similar to estimates of leukaemic cells in vivo (doubling time 53-442 h). Authenticity was confirmed by genetic fingerprinting, which also demonstrated the potential stability of long-term cultures. In vitro glucocorticoid resistance correlated well with that measured ex vivo, but all lines were significantly more sensitive to vincristine than primary specimens. Sensitivity to methotrexate was inversely correlated to that of glucocorticoids and L-asparaginase, indicating possible reciprocity in resistance mechanisms. A cell line identified as highly methotrexate resistant (IC50 > 8000-fold higher than other lines) was derived from a patient receiving escalating doses of the drug, indicating in vivo selection of resistance as a cause of relapse. Many of these lines are suitable as models to study naturally occurring resistance phenotypes in paediatric ALL.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Drug resistance profile of ALL cell lines. IC50 values for T-ALL (open, n=15) vs B-lineage ALL (shaded, n=7) cell lines. Boxes indicate medians and inter-quartile range, whiskers indicate 10th and 90th percentiles and dots indicate outliers; values are calculated as log2 molarity (μM) for all drugs, except ASP which is given as log2 IU ml−1.
Figure 2
Figure 2
Comparison of resistance profiles in patients and cell lines. Data indicate total IC50 ranges determined from published studies of diagnosis (PD) and relapse (PR) patient specimens, and from cell lines derived from diagnosis (CLD) and relapse (CLR) specimens in the present study. Median values from individual studies are indicated as tick marks. Median values from the single study of MPRED resistance in patient specimens are indicated as crosses. Data represent combined T and B lineages; values are μg ml−1 for all drugs, except ASP which is given as IU ml−1.
Figure 3
Figure 3
Resistance profiles of MPRED, DEX, ASP and MTX in T-ALL cell lines. Delta IC50 scores (Log2 IC50 – median Log2 IC50) were calculated for each drug and cell lines plotted from left to right according to their Delta IC50 rank for MPRED.

References

    1. Adamson PC, Poplack DG, Balis FM (1994) The cytotoxicity of thioguanine vs mercaptopurine in acute lymphoblastic leukemia. Leukemia Res 18: 805–810 - PubMed
    1. Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR (1988) Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48: 589–601 - PubMed
    1. Balis FM, Holcenberg JS, Poplack DG, Ge J, Sather HN, Murphy RF, Ames MM, Waskerwitz MJ, Tubergen DG, Zimm S, Gilchrist GS, Bleyer WA (1998) Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group and pediatric oncology branch study. Blood 92: 3569–3577 - PubMed
    1. Catts VS, Farnsworth ML, Haber M, Norris MD, Lutze-Mann LH, Lock RB (2001) High level resistance to glucocorticoids associated with a dysfunctional glucocorticoid receptor in childhood acute lymphoblastic leukemia cells selected for methotrexate resistance. Leukemia 15: 929–935 - PubMed
    1. Cooperman J, Neely R, Teachey DT, Grupp S, Choi JK (2004) Cell division rates of primary human precursor B cells in culture reflect in vivo rates. Stem Cells 22: 1111–1120 - PubMed

Publication types

Substances